SEC Form 4 · accession 0001185185-17-002244
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Exec. Chairman & CEO · Director
Period of report
Oct 18, 2017
Accepted (ET)
Nov 3, 2017 · 5:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Oct 18, 2017 | D | 25,000 | $0.41 | D | 767,289 | I | By Spouse |
| Common stockF1 | Oct 18, 2017 | D | 25,000 | $0.40 | D | 742,289 | I | By Spouse |
| Common stockF1 | Oct 18, 2017 | D | 25,000 | $0.40 | D | 717,289 | I | By Spouse |
| Common stockF1 | Oct 18, 2017 | D | 25,000 | $0.41 | D | 692,289 | I | By Spouse |
| Common stockF1 | Oct 25, 2017 | D | 25,000 | $0.41 | D | 667,289 | I | By Spouse |
| Common stockF1 | Oct 25, 2017 | D | 11,834 | $0.41 | D | 655,455 | I | By Spouse |
| Common stockF1 | Nov 1, 2017 | D | 13,166 | $0.45 | D | 642,289 | I | By Spouse |
| Common stockF1 | Nov 1, 2017 | D | 25,000 | $0.45 | D | 617,289 | I | By Spouse |
| Common stockF1 | Nov 2, 2017 | D | 25,000 | $0.46 | D | 592,289 | I | By Spouse |
| Common stockF1 | Nov 3, 2017 | D | 100,000 | $0.51 | D | 492,289 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares held directly by CEO's spouse